{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:18:08Z","timestamp":1777774688539,"version":"3.51.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunization during pregnancy (IP) against pertussis protects young infants, but the maternally derived antibodies blunt the quantity of infants\u2019 antibody responses to their primary vaccination. While the blunting effect has been well studied for antibody quantity, potential blunting that would affect functional characteristics of these antibodies is less studied. This study evaluated the effect of IP on the epitopes and avidity of anti\u2013pertussis toxin (PT) immunoglobulin G (IgG) antibodies in infants and their mothers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective open-label controlled clinical trial, 47 pregnant women received diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine booster, and 22 pregnant women who were not vaccinated served as controls. Sixty-nine infants received hexavalent DTaP vaccine at 3 and 5 months of age. The binding strength of anti-PT IgG antibodies and their ability to inhibit epitope-specific binding of mouse monoclonal antibodies were measured with enzyme-linked immunosorbent assays in both maternal and infant samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In both study groups, antibodies in cord blood showed higher epitope-specific inhibition and avidity than what was induced in infants after 2 primary vaccine doses, at age 6 months. Higher anti-PT IgG concentrations (P &amp;lt; .001) and epitope-specific inhibition targeting 1B7 (P = .049) and 11E6 (P = .02) were noted at age 6 months in control group infants, suggesting epitope-specific blunting in the IP group. No difference was observed in the avidity of anti-PT IgG at age 6 months between 2 study groups. The increase in avidity after vaccination was the highest in those mothers and infants with lower baseline avidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IP decreased primary vaccination-induced antibody responses disproportionately against different PT epitopes in infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trials Registration<\/jats:title>\n                    <jats:p>European Union Clinical Trial database (EudraCT no. 2019-001986-34; https:\/\/www.clinicaltrialsregister.eu).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag048","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:57:22Z","timestamp":1769086642000},"page":"e963-e972","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Pertussis Vaccination During Pregnancy on the Binding Epitopes and Avidity of Anti\u2013Pertussis Toxin Immunoglobulin G Antibodies in Infants and Their Mothers"],"prefix":"10.1093","volume":"233","author":[{"given":"Aapo","family":"Knuutila","sequence":"first","affiliation":[{"name":"Research Centre for Infections and Immunity, Institute of Biomedicine, University of Turku , Turku ,","place":["Finland"]},{"name":"Department of Life Technologies, University of Turku , Turku ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-5032","authenticated-orcid":false,"given":"Lauri","family":"Ivaska","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Medicine, Turku University Hospital, and University of Turku , Turku ,","place":["Finland"]},{"name":"InFLAMES Research Flagship Center, University of Turku , Turku ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-1580","authenticated-orcid":false,"given":"Alex-Mikael","family":"Barkoff","sequence":"additional","affiliation":[{"name":"Research Centre for Infections and Immunity, Institute of Biomedicine, University of Turku , Turku ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-9674","authenticated-orcid":false,"given":"Pieter","family":"van Gageldonk","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control , Bilthoven ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Buisman","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control , Bilthoven ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7746-3949","authenticated-orcid":false,"given":"Jussi","family":"Mertsola","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Medicine, Turku University Hospital, and University of Turku , Turku ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[{"name":"Research Centre for Infections and Immunity, Institute of Biomedicine, University of Turku , Turku ,","place":["Finland"]},{"name":"InFLAMES Research Flagship Center, University of Turku , Turku ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2026042913514588900_jiag048-B1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026042913514588900_jiag048-B3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis","volume":"181","author":"Taranger","year":"2000","journal-title":"J Infect Dis"},{"key":"2026042913514588900_jiag048-B5","first-page":"2871","article-title":"Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries","volume":"12","author":"Berbers","year":"2021","journal-title":"NatCommun"},{"key":"2026042913514588900_jiag048-B6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1186\/s12889-024-18968-y","article-title":"Global burden of pertussis in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019","volume":"24","author":"Nie","year":"2024","journal-title":"BMC Public Health"},{"key":"2026042913514588900_jiag048-B7","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"2026042913514588900_jiag048-B8","doi-asserted-by":"crossref","first-page":"107047","DOI":"10.1016\/j.ijid.2024.107047","article-title":"Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: real-world evidence","volume":"144","author":"Chaithongwongwatthana","year":"2024","journal-title":"Int J Infect Dis"},{"key":"2026042913514588900_jiag048-B9","doi-asserted-by":"crossref","first-page":"2204146","DOI":"10.1080\/22221751.2023.2204146","article-title":"Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants","volume":"12","author":"Knuutila","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"2026042913514588900_jiag048-B10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1473-3099(18)30717-5","article-title":"Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial","volume":"19","author":"Barug","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026042913514588900_jiag048-B11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eclinm.2019.06.010","article-title":"The effect of maternal immunisation during pregnancy on infant vaccine responses","volume":"13","author":"Zimmermann","year":"2019","journal-title":"EClinicalMedicine"},{"key":"2026042913514588900_jiag048-B12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1542\/peds.96.3.580","article-title":"The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids","volume":"96","author":"Englund","year":"1995","journal-title":"Pediatrics"},{"key":"2026042913514588900_jiag048-B13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(25)00072-6","article-title":"The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial","volume":"25","author":"Saso","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026042913514588900_jiag048-B14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/CVI.00561-10","article-title":"Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization","volume":"18","author":"Sutherland","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"2026042913514588900_jiag048-B15","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1002\/cti2.1161","article-title":"Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations","volume":"9","author":"Knuutila","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"2026042913514588900_jiag048-B16","first-page":"3369","article-title":"Protective activities in mice of monoclonal antibodies against pertussis toxin","volume":"58","author":"Sato","year":"1990","journal-title":"InfectImmun"},{"key":"2026042913514588900_jiag048-B17","doi-asserted-by":"crossref","first-page":"316ra195","DOI":"10.1126\/scitranslmed.aad0966","article-title":"A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough","volume":"7","author":"Nguyen","year":"2015","journal-title":"Sci Transl Med"},{"key":"2026042913514588900_jiag048-B18","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"2026042913514588900_jiag048-B19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1126\/science.272.5258.54","article-title":"Immunological memory and protective immunity: understanding their relation","volume":"272","author":"Ahmed","year":"1996","journal-title":"Science"},{"key":"2026042913514588900_jiag048-B20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(98)00040-1","article-title":"Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines.","volume":"16","author":"Salmaso","year":"1998","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/toxins13080508","article-title":"Evaluation of anti-PT antibody response after pertussis vaccination and infection: the importance of both quantity and quality","volume":"13","author":"Barkoff","year":"2021","journal-title":"Toxins (Basel)"},{"key":"2026042913514588900_jiag048-B22","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2014.08.038","article-title":"The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels\u2014a prospective study","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/21505594.2017.1296998","article-title":"Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium","volume":"8","author":"Cabore","year":"2017","journal-title":"Virulence"},{"key":"2026042913514588900_jiag048-B24","first-page":"422","article-title":"Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections","volume":"46","author":"Sato","year":"1984","journal-title":"InfectImmun"},{"key":"2026042913514588900_jiag048-B25","doi-asserted-by":"crossref","first-page":"e2174782","DOI":"10.1080\/22221751.2023.2174782","article-title":"Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection","volume":"12","author":"Knuutila","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"2026042913514588900_jiag048-B26","doi-asserted-by":"crossref","first-page":"2547720","DOI":"10.1080\/22221751.2025.2547720","article-title":"Prior immunological memory to pertussis toxin affects the avidity development of anti-PT IgG antibodies after acellular pertussis booster vaccination","volume":"14","author":"Knuutila","year":"2025","journal-title":"Emerg Microb Infect"},{"key":"2026042913514588900_jiag048-B27","author":"Knuutila"},{"key":"2026042913514588900_jiag048-B28","doi-asserted-by":"crossref","first-page":"eaay9258","DOI":"10.1126\/sciadv.aay9258","article-title":"Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons","volume":"6","author":"Nguyen","year":"2020","journal-title":"Sci Adv"},{"key":"2026042913514588900_jiag048-B29","doi-asserted-by":"crossref","first-page":"103821","DOI":"10.1016\/j.jri.2023.103821","article-title":"Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy in comparison with unvaccinated controls","volume":"156","author":"Sabharwal","year":"2023","journal-title":"J Reprod Immunol"},{"key":"2026042913514588900_jiag048-B30","doi-asserted-by":"crossref","first-page":"126573","DOI":"10.1016\/j.vaccine.2024.126573","article-title":"Association of baseline cytokines with antibody concentrations after diphtheria-tetanus-acellular pertussis booster vaccination in Finnish children","volume":"44","author":"Anabe","year":"2025","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41390-022-02154-0","article-title":"A prospective study of the infant gut microbiome in relation to vaccine response","volume":"93","author":"Moroishi","year":"2023","journal-title":"Pediatr Res"},{"key":"2026042913514588900_jiag048-B32","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1016\/j.vaccine.2013.09.026","article-title":"Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations","volume":"31","author":"Yucesoy","year":"2013","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0264-410X(95)00230-X","article-title":"The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies","volume":"14","author":"Ibsen","year":"1996","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B34","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1016\/j.vaccine.2015.05.075","article-title":"Avidity of maternal pertussis antibodies after vaccination during pregnancy","volume":"33","author":"Maertens","year":"2015","journal-title":"Vaccine"},{"key":"2026042913514588900_jiag048-B35","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3389\/fimmu.2019.02423","article-title":"The effect of timing of tetanus-diphtheria-acellular pertussis vaccine administration in pregnancy on the avidity of pertussis antibodies","volume":"10","author":"Abu-Raya","year":"2019","journal-title":"Front Immunol"},{"key":"2026042913514588900_jiag048-B36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1203\/00006450-199004000-00009","article-title":"Maternofetal transfer of IgG anti-Escherichia coli antibodies with enhanced avidity and opsonic activity in very premature neonates","volume":"27","author":"Sennhauser","year":"1990","journal-title":"Pediatr Res"},{"key":"2026042913514588900_jiag048-B37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1651-2227.1998.tb00972.x","article-title":"Placental transfer favours high avidity IgG antibodies","volume":"87","author":"Avanzini","year":"1998","journal-title":"Acta Paediatr"},{"key":"2026042913514588900_jiag048-B38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/antib8020030","article-title":"The ligands for human IgG and their effector functions","volume":"8","author":"de Taeye","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"2026042913514588900_jiag048-B39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","article-title":"The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans","volume":"13","author":"Firan","year":"2001","journal-title":"Int Immunol"},{"key":"2026042913514588900_jiag048-B40","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"2026042913514588900_jiag048-B41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature","volume":"87","author":"van den Berg","year":"2011","journal-title":"Early Hum Dev"},{"key":"2026042913514588900_jiag048-B42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QCO.0000000000000372","article-title":"Placental transfer of antibody and its relationship to vaccination in pregnancy","volume":"30","author":"Calvert","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"2026042913514588900_jiag048-B43","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.vaccine.2015.02.059","article-title":"Immunization of pregnant women against pertussis: the effect of timing on antibody avidity","volume":"33","author":"Raya","year":"2015","journal-title":"Vaccine"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag048\/66593171\/jiag048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/4\/e963\/66593171\/jiag048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/4\/e963\/66593171\/jiag048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:51:57Z","timestamp":1777485117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/233\/4\/e963\/8442751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,1,28]]},"published-print":{"date-parts":[[2026,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag048","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,15]]},"published":{"date-parts":[[2026,1,28]]}}}